Policy bypasses FDA safeguards, alarming drug safety and cancer experts Posted Oct 28, 2026 2:40 PM CDT
Rob Quinn is a writer at various outlets, including GVTC Communications and StockCharts.com. He covers a range of topics including elections, government, and international affairs, with a focus on finance, politics, and world news, particularly in North America and Latin America. Rob's work has been featured in prominent platforms such as MSN, Newser, and iHeartRadio.